<?xml version="1.0" encoding="UTF-8"?>
<ref id="B98-microorganisms-08-00085">
 <label>98.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Calic</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Cappelen-Smith</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Hodgkinson</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>McDougall</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Cuganesan</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Brew</surname>
    <given-names>B.J.</given-names>
   </name>
  </person-group>
  <article-title>Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab</article-title>
  <source>J. Clin. Neurosci.</source>
  <year>2015</year>
  <volume>22</volume>
  <fpage>598</fpage>
  <lpage>600</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jocn.2014.08.016</pub-id>
  <pub-id pub-id-type="pmid">25523125</pub-id>
 </element-citation>
</ref>
